The move came three days after the inauguration of President Barack Obama, a Democrat who had been expected to rescind some of the federal funding restrictions placed on such research.
The California biotechnology company plans to initiate a clinical trial in patients with acute spinal cord injury.
“This marks the beginning of what is potentially a new chapter in medical therapeutics – one that reaches beyond pills to a new level of healing: the Read the rest of this entry »
Ex-Beaumonter, pioneering doctor wants Obama to focus on stem cell research
January, 4, 2009
He was a 35-year-old medical researcher when he had a eureka moment – discovering a vaccine to treat cervical cancer and becoming the subject of a presidential debate.
It’s been 40 years since former Beaumont resident, Dr. Roland Pattillo, discovered the earliest stages of development from the stem cells extracted from the placenta walls.
For his works Read the rest of this entry »
NEW YORK (Associated Press) – Cell Therapeutics Inc. said Monday the Food and Drug Administration granted priority review for an application seeking expanded use of the biotechnology company’s cancer drug Zevalin.
Zevalin is already approved to treat a form of non-Hodgkin’s lymphoma, which is a cancer affecting the lymph and immune system, in patients who have relapsed. The company now seeks approval for the drug in patients who have responded to Read the rest of this entry »
MONDAY, Oct. 20 (HealthDay News) — It’s been a mystery for medical researchers: How does the AIDS virus bring itself back to life after powerful drugs allow infected people to eliminate all signs of the disease in their blood?
Now, new research suggests HIV can hibernate inside a small number of cells — or even a single cell — until re-emerging to wreak havoc.
Study co-author Huldrych Gunthard, a researcher at University Hospital Zurich, in Read the rest of this entry »
Drugs, cell phones found in QC jail
By Nancy C. Carvajal
MANILA — A surprise inspection of inmates cells at the Quezon City jail Sunday morning yielded more than 200 sachets of drugs, drug paraphernalia, cell phones and deadly weapons.
The operation, which was ordered by Senior Supt. Emilio Culang, city jail warden, led to the seizure of at least 250 grams of dried marijuana leaves, 206 sachets of marijuana and shabu, several bottles Read the rest of this entry »
Tuesday, Jan. 13
11 a.m. ET
to discuss the challenges public health researchers are facing because many homes, that they use to survey, no longer have land lines.
or during the discussion.
Good morning chatters! Welcome to the Live Online about the story in yesterday’s Post about some of the difficulties in getting representative and reproducible data from population-based surveys, such as those run by the Centers for Disease Control and Read the rest of this entry »
In short, the Bradley-Brooks family has joined the ranks of the underinsured, a growing population of residents who have health insurance but it covers less and costs more than before. The underinsured includes those who spend more than 10 percent of their income on health care or whose deductibles exceed 5 percent, according to the Commonwealth Fund, a private health-care research foundation.
In June, the foundation reported that the number of Read the rest of this entry »
BOSTON, Sep 11, 2008 (Thomson Financial via COMTEX) –
— Cell Genesys Inc. Thursday said the Food and
Drug Administration has placed a partial clinical hold on the GVAX Phase 3
program for prostate cancer as a result of the company’s announcement to
terminate the VITAL-2 Phase 3 trial for this product.
The company said it had expected the move by the FDA.
Cell Genesys said the communication from FDA has no impact on the previously
announced Read the rest of this entry »
New York, NY
(NBC) — The Food and Drug Administration has cleared the way for the first-ever human trial of a medical treatment, derived from embryonic stem cells.
The company plans to start testing this embryonic stem cell therapy on patients with spinal cord injuries.
Members of one spinal cord injury peer support group are buzzing about Menlo Park Company’s efforts to use embryonic stem cell therapy on people with spinal cord injuries. Read the rest of this entry »
This news release may contain forward-looking statements made pursuant to
the “safe harbor” provisions of the Private Securities Litigation Reform Act
of 1995. Investors are cautioned that such forward-looking statements in this
press release regarding potential applications of Neuralstem’s technologies
constitute forward-looking statements that involve risks and uncertainties,
including, without limitation, risks inherent in the development Read the rest of this entry »